Melanoma of the head and neck and its treatment are complex issues. The behavior of head and neck melanoma is aggressive, and it has an overall poorer prognosis than that of other skin sites.
Methods
The authors review current data on the treatment of head and neck melanoma, including both cutaneous and mucosal melanoma.
Results
Current understanding of the behavior of head and neck melanoma is reviewed and treatment stratagems are presented. Controversies in treatment include lymphoscintigraphy with sentinel node biopsy, nodal dissection, margin size, role of radiation therapy, and reconstruction. The management goal is to treat melanoma aggressively while minimizing the effects of treatment on patient quality of life.
Conclusions
Due to its aggressiveness, head and neck melanoma should be treated aggressively when morbidity is not significantly increased. Patient specific treatment is imperative.
References
1.
JemalA., MurrayT., WardE.. Cancer statistics, 2005.CA Cancer J Clin.2005; 55: 10–30. Erratum in: CA Cancer J Clin. 2005; 55: 259.
2.
RiesL.A.G., EisnerM.P., KosaryC.L., eds. SEER Cancer Statistics Review, 1975-2002.Bethesda, Md: National Cancer Institute; 2004. Available at: http://seer.cancer.gov/csr/1975_2002. Accessed September 6, 2005.
3.
GandiniS., SeraF., CattaruzzaM.S.. Meta-analysis of risk factors for cutaneous melanoma, II: sun exposure.Eur J Cancer.2005; 41: 45–60.
4.
BerwickM., ArmstrongB.K., Ben-PoratL.. Sun exposure and mortality from melanoma.J Natl Cancer Inst.2005; 97: 195–199.
5.
GandiniS., SeraF., CattaruzzaM.S.. Meta-analysis of risk factors for cutaneous melanoma, I: common and atypical naevi.Eur J Cancer.2005; 41: 28–44.
6.
HolmanC.D., ArmstrongB.K.. Pigmentary traits, ethnic origin, benign nevi, and familial history as risk factors for cutaneous malignant melanoma.J Natl Cancer Inst.1984; 72: 257–266.
7.
RigelD.S.. Epidemiology and prognostic factors in malignant melanoma.Ann Plast Surg.1992; 28: 7–8.
8.
BallantyneA.J.. Malignant melanoma of the skin of the head and neck: an analysis of 405 cases.Am J Surg.1970; 120: 425–431.
9.
ByersR.M., SmithJ.L., RussellN.. Malignant melanoma of the external ear: review of 102 cases.Am J Surg.1980; 140: 518–521.
10.
UristM.M., BalchC.M., SoongS.J.. Head and neck melanoma in 534 clinical stage I patients: a prognostic factors analysis and results of surgical treatment.Ann Surg.1984; 200: 769–775.
11.
LoreeT.R., SpiroR.H.. Cutaneous melanoma of the head and neck.Am J Surg.1989; 158: 388–391.
12.
FisherS.R.. Cutaneous malignant melanoma of the head and neck.Laryngoscope.1989; 99 (8 pt 1): 822–836.
13.
AnderssonA.P., GottliebJ., DrzewieckiK.T.. Skin melanoma of the head and neck: prognostic factors and recurrence-free survival in 512 patients.Cancer.1992; 69: 1153–1156.
14.
RingborgU., AfzeliusL.E., LagerlofB.. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group.Cancer.1993; 71: 751–758.
CloseL.G., GoepfertH., BallantyneA.J.. Malignant melanoma of the scalp.Laryngoscope.1979; 89: 1189–1196.
17.
EssnerR., WongJ.H., EconomouJ.S.. Prognostic significance of melanoma arising in the scalp.Am J Surg.1988; 156: 314–317.
18.
SternS.J., GuillamondeguiO.M.. Mucosal melanoma of the head and neck.Head Neck.1991; 13: 22–27.
19.
KingdomT.T., KaplanM.J.. Mucosal melanoma of the nasal cavity and paranasal sinuses.Head Neck.1995; 17: 184–189.
20.
PatelS.G., PrasadM.L., EscrigM.. Primary mucosal malignant melanoma of the head and neck.Head Neck.2002; 24: 247–257.
21.
MedinaJ.E., FerlitoA., PellitteriP.K.. Current management of mucosal melanoma of the head and neck.J Surg Oncol.2003; 83: 116–122.
22.
YiiN.W., EisenT., NicolsonM.. Mucosal malignant melanoma of the head and neck: the Marsden experience over half a century.Clin Oncol (R Coll Radiol).2003; 15: 199–204.
23.
PrasadM.L., BusamK.J., PatelS.G.. Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract.Arch Pathol Lab Med.2003; 127: 997–1002.
24.
PrasadM.L., PatelS.G., HuvosA.G.. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage I (lymph node-negative) tumors.Cancer.2004; 100: 1657–1664.
OwensJ.M., RobertsD.B., MyersJ.N.. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region.Arch Otolaryngol Head Neck Surg.2003; 129: 864–868.
27.
TemamS., MamelleG., MarandasP.. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.Cancer.2005; 103: 313–319.
28.
BalchC.M., BuzaidA.C., SoongS.J.. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.J Clin Oncol.2001; 19: 3635–3648.
29.
GreeneF.L., PageD.L., FlemingI.D., eds. AJCC Cancer Staging Manual.6th ed.New York, NY: Springer Verlag; 2002: 209–217.
30.
BalchC.M., SoongS.J., GershenwaldJ.E.. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.J Clin Oncol.2001; 19: 3622–3634.
31.
AbbasiN.R., ShawH.M., RigelD.S.. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.JAMA.2004; 292: 2771–2776.
32.
KrownS.E., ChapmanP.B.. Defining adequate surgery for primary melanoma.N Engl J Med.2004; 350: 823–825.
33.
LensM.B., DawesM., GoodacreT.. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision.Arch Surg.2002; 137: 1101–1105.
34.
BalloM.T., BonnenM.D., GardenA.S.. Adjuvant irradiation for cervical lymph node metastases for melanoma.Cancer.2003; 97: 1789–1796.
35.
BonnenM.D., BalloM.T., MyersJ.N.. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.Cancer.2004; 100: 383–389.
36.
MortonD.L., ThompsonJ.F., EssnerR.. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.Ann Surg.1999; 230: 453–465.
37.
McMastersK.M., NoyesR.D., ReintgenD.S.. Lessons learned form the Sunbelt Melanoma Trial.J Surg Oncol.2004; 86: 212–223.
38.
ReintgenD., PendasS., JakubJ.. National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial.Semin Oncol.2004; 31: 363–373.
39.
O'BrienC.J., Petersen-SchaeferK., RuarkD.. Radical, modified, and selective neck dissection for cutaneous malignant melanoma.Head Neck.1995; 17: 232–241.
40.
PathakI., O'BrienC.J., Petersen-SchaeferK.. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?Head Neck.2001; 23: 785–790.
41.
O'BrienC.J., McNeilE.B., McMahonJ.D.. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland.Head Neck.2001; 23: 744–748.
42.
LeeR.J., GibbsJ.F., ProulxG.M.. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.Int J Radiat Oncol Biol Phys.2000; 46: 467–474.
43.
BowsherW.G., TaylorB.A., HughesL.E.. Morbidity, mortality and local recurrence following regional node dissection for melanoma.Br J Surg.1986; 73: 906–908.
44.
BogleM., KellyP., ShenaqJ.. The role of soft tissue reconstruction after melanoma resection in the head and neck.Head Neck.2001; 23: 8–15.
